|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00690 UNI-BIO GROUP
Nominal 
0.097 -0.003 (-3.000%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | 17.009% | 17.848% | 20.179% | 13.753% | -7.531% |
| ROAE (%) | 25.261% | 28.405% | 31.367% | 20.871% | -10.773% |
| Return on Capital Employed (%) | 19.596% | 21.006% | 24.009% | 19.045% | -11.176% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 83.172% | 83.379% | 81.041% | 76.055% | 78.382% |
| EBITDA Margin (%) | 20.263% | 19.957% | 19.024% | 13.607% | 0.239% |
| Pre-tax Profit Margin (%) | 17.318% | 16.487% | 15.659% | 9.831% | -5.663% |
| Net Profit Margin (%) | 15.920% | 14.969% | 14.622% | 8.746% | -5.543% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 3.229 X | 2.581 X | 2.074 X | 2.220 X | 2.185 X |
| Quick Ratio (X) | 2.872 X | 2.308 X | 1.757 X | 1.845 X | 1.755 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 28.726% | 37.080% | 37.273% | 33.414% | 34.861% |
| Total Debt / Total Assets (%) | 16.860% | 22.256% | 13.732% | 7.752% | 2.092% |
| Net Debt / Total Assets (%) | -12.257% | 9.695% | -17.790% | -25.830% | -29.153% |
| Total Debt / Shareholders' Funds (%) | 23.656% | 35.372% | 21.891% | 11.642% | 3.212% |
| Long Term Debt / Shareholders' Funds (%) | 14.400% | 20.176% | 14.621% | 3.836% | 0.565% |
| Net Debt / Shareholders' Funds (%) | -17.197% | 15.409% | -28.361% | -38.791% | -44.755% |
| Net Cash / (Debt) ($) | 71.065M | (50.178M) | 72.937M | 75.544M | 78.011M |
| Net Cash / (Debt) per share ($) | 0.012 | (0.008) | 0.011 | 0.012 | 0.012 |
| Total Debt / Capital Employed (%) | 20.526% | 29.231% | 19.071% | 11.212% | 3.194% |
| Interest Coverage Ratio (X) | -- | 77.678 X | 97.935 X | 116.125 X | N/A |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 130.934 Day | 139.327 Day | 139.494 Day | 127.333 Day | 134.318 Day |
| Receivables Turnover (Day) | 50.019 Day | 40.746 Day | 41.825 Day | 53.674 Day | 75.600 Day |
| Payables Turnover (Day) | 11.331 Day | 8.100 Day | 5.489 Day | 4.364 Day | 4.697 Day |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 93,327 |
| %Change | 12.749% |
| EPS / (LPS) | HKD 0.016 |
| NBV Per Share ($) | HKD 0.069 |